Dictionaries Armenian-English English-Armenian MeSH Feedback
UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
F F F- F0 FA FB FC FD FE FF FG FH FI FJ FK FL FM FN FO FP FR FS FT FU FX FY
selected terms: 2,504
 << Prev ▫ 1 ▫ .. ▫ 7 ▫ 8 ▫ 9 ▫ 10 ▫ 11 ▫ 12 ▫ 13 ▫ .. ▫ 26 ▫ Next >>
 page 10 of 26

901. FETAL/NEONATAL JAUND NOS
[ ] (UMLS (ICD9CM) C0270206) =Disease or Syndrome
951. FGF6
[This gene is involved in angiogenesis and cell proliferation. ( NCI )] (UMLS (NCI) C0812296) FGF6 Gene;
Fibroblast Growth Factor 6 Gene =Gene or Genome
902. FETISHISM
[A condition in which inanimate objects are utilized as a preferred or exclusive method of stimulating erotic arousal. ( MSH )] (UMLS (ICD9CM) C0015957) =Mental or Behavioral Dysfunction =Paraphilias;
952. FGF6
[Fibroblast Growth Factor 6 is encoded by the HST2 proto-oncogene and belongs to the heparin-binding growth factor family. FGF6 exhibits strong mitogenic and angiogenic properties and may be expressed by cells with platelet/megakaryocytic differentiation potential. (from Swiss-Prot P10767 and NCI) ( NCI )] (UMLS (NCI) C1448584) FGF-6;
Fibroblast Growth Factor 6;
HBGF-6;
HST-2 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
903. fetomaternal circulation
[vessels, supply, and flow of blood propelled through the umbilical vessels (allantoic), intervillous space (intervillous), placenta, chorionic villi and the fetal heart. ( CSP )] (UMLS (CSP) C0597280) =Organ or Tissue Function ;
=reproductive system circulation;
=umbilical cord;
Blood, Cord;
placental transfer;
953. FGF7
[This gene plays a role in cellular biogenesis, growth, organization and proliferation. It is also involved in the inhibition of apoptosis. ( NCI )] (UMLS (NCI) C0919507) FGF7 Gene;
Fibroblast Growth Factor 7 (Keratinocyte Growth Factor) Gene;
=Gene or Genome ;
904. FETOPEL DISPROP-ANTEPART
(UMLS (ICD9CM) C1142292) Fetopelvic disproportion, antepartum =Disease or Syndrome
954. FGF8
[This gene is involved in development and organogenesis. ( NCI )] (UMLS (NCI) C1333539) FGF8 Gene;
Fibroblast Growth Factor 8 (Androgen-Induced) Gene =Gene or Genome ;
905. FETOPELV DISPROP-UNSPEC
(UMLS (ICD9CM) C1142293) Fetopelvic disproportion, unspecified as to episode of care =Disease or Syndrome
955. FGF9
[Expressed in glia and neurons by human FGF9 Gene (FGF family), 208-aa 23-kDa (precursor) N-glycosylated monomeric secreted Fibroblast Growth Factor 9 has glial growth-stimulating effects and is likely involved in glial cell growth and differentiation, gliosis, and differentiation or survival of neuronal cells. Three molecular species of 30-kDa, 29-kDa and 25-kDa, cleaved at Leu-4, Val-13 and Ser-34 respectively, are found. Expression may be dependent on Sonic hedgehog signaling. (NCI) ( NCI )] (UMLS (NCI) C0386595) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
906. FETOPELV DISPROPOR-DELIV
[ ] (UMLS (ICD9CM) C0156982) =Disease or Syndrome ;
956. FGF9
[This gene plays a role in the promotion of cellular growth/proliferation and negative regulation of apoptosis. It is also involved in glial cell development. ( NCI )] (UMLS (NCI) C1333540) FGF9 Gene;
Fibroblast Growth Factor 9 (Glia-Activating Factor) Gene =Gene or Genome ;
907. Fetopelvic disproportion
[A condition in which the HEAD of the FETUS is larger than the mother's PELVIS through which the fetal head must pass during a vaginal delivery. ( MSH )] (UMLS (ICD9CM) C0085988) =Finding
957. FGFR Signaling Adaptor
[Encoded by human FRS2 Gene, 508-aa 56.8-kD FGFR Substrate 2 contains a myristylation sequence, a PTB domain, and 4 potential GRB2/SHP2-binding sites. FGFR-mediated Tyr-phosphorylated FRS2 binds to FGFR1 and GRB2/SOS in response to FGF or NGF. An FGFR1 juxtamembrane segment and the PTB domain appear to interact and mediate FRS Tyr phosphorylation. Myristylation is essential for FRS2 membrane localization, Tyr phosphorylation, GRB2/SOS recruitment, and MAPK activation. FRS2A is Thr phosphorylated by MAPK in response to FGF, insulin, EGF, and PDGF. FRS2 may function as a lipid-anchored docking protein that targets signaling molecules to the plasma membrane in response to FGF to link receptor activation with MAPK and other pathways essential for cell growth and differentiation. (NCI) ( NCI )] (UMLS (NCI) C0540129) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
908. fetus cell
[ ] (UMLS (CSP) C0920514) =Embryonic Structure
958. FGFR Substrate 3
[Encoded by human FRS3 Gene, 492-aa 54-kDa plasma membrane-associated FGFR Substrate 3 is an FGFR substrate that links FGFR stimulation to RAS activators. Similar (49% identical) to FRS2, FRS3 also contains a myristylation sequence, a PTB domain, and Tyr-containing motifs that govern GRB2 and SHP2 recruitment. FRS2 and FRS3 bind directly to FGFR1; an FGFR1 juxtamembrane segment and the PTB domain appear to interact and mediate FRS Tyr phosphorylation. (NCI) ( NCI )] (UMLS (NCI) C1333545) Fibroblast Growth Factor Receptor Substrate 3;
FRS2B;
FRS2-Beta;
FRS3;
SNT2;
SUC1-Associated Neurotrophic Factor Target 2 =Amino Acid, Peptide, or Protein; Biologically Active Substance
909. fetus chemotherapy
[ ] (UMLS (CSP) C0920743) =Therapeutic or Preventive Procedure ;
959. FGFR1
[Acidic fibroblast growth factor stimulates tyrosine kinase activity of FGFR1, the receptor for acidic FGF. The receptor is a transmembrane protein that contains three extracellular Ig-like domains, an unusual acidic region, and an intracellular tyrosine kinase domain. (from OMIM 136350 and NCI) ( NCI )] (UMLS (NCI) C0170936) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
910. fetus circulation
[ ] (UMLS (CSP) C0920516) =Organ or Tissue Function
960. FGFR1
[This gene plays a role in mitogenesis and differentiation. ( NCI )] (UMLS (NCI) C0919509) FGFR1 Gene;
Fibroblast Growth Factor Receptor 1 (FMS-Related Tyrosine Kinase 2, Pfeiffer Syndrome) Gene;
=Gene or Genome ;
911. fetus culture
[ ] (UMLS (CSP) C0920517) =Research Activity
961. FGFR1 Oncogene Partner
[Encoded by human FGFR1OP Gene, ubiquitous 399-aa 43-kDa hydrophilic FGFR1 Oncogene Partner protein contains N- and C-terminal alpha helices harboring leucine-rich repeats. FOP may play a role in erythroid cell proliferation and differentiation. (NCI) ( NCI )] (UMLS (NCI) C0764082) Fibroblast Growth Factor Receptor 1 Oncogene Partner;
FOP =Amino Acid, Peptide, or Protein; Receptor ;
912. fetus drug adverse effect
[ ] (UMLS (CSP) C0920518) =Injury or Poisoning
962. FGFR1 Oncogene Partner Gene
[This gene is involved in the regulation of cell shape, polarity and motility. ( NCI )] (UMLS (NCI) C1333541) FGFR1OP;
FGFR1OP Gene =Gene or Genome ;
913. fetus growth disorder
[ ] (UMLS (CSP) C0920519) =Disease or Syndrome
963. FGFR2
[KGF is a potent mitogenic paracrine mediator of epithelial cell proliferation. The keratinocyte growth factor receptor is a FGFR RTK family member with three extracellular Ig-like domains, a single membrane-spanning segment, and a cytoplasmic tyrosine kinase domain. Two alternatively spliced FGFR2 gene products, KGFR and BEK, vary in sequence within the third extracellular Ig loop, which influence ligand-binding characteristics. Control of these alternative splice sites is thought to involve transacting factors. These receptors also have different patterns of expression. KGFR appears to have a role in skin development; BEK is preferentially expressed in osteogenesis. Dimerization of the FGFR2 ectodomain is induced by binding to FGF1 and a heparin decasaccharide, essential in FGF signaling. (from OMIM 176943 and NCI) ( NCI )] (UMLS (NCI) C0209706) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
914. fetus membrane
[Extra-embryonic tissues that contain the FETUS during PREGNANCY. They provide the support to accommodate FETAL DEVELOPMENT. Depending on the species, their structure and complexity vary greatly in the different forms of PLACENTA. These membranes undergo rupture during PARTURITION. ( MSH )] (UMLS (CSP) C0015943) =Embryonic Structure ;
964. FGFR2
[This gene plays a role in mitogenesis and differentiation and mutations in the gene are associated with craniosynostotic syndromes and bone malformations. ( NCI )] (UMLS (NCI) C1333542) FGFR2 Gene;
Fibroblast Growth Factor Receptor 2 Gene =Gene or Genome ;
915. Fetus or newborn affected by complications of placenta, cord, and membranes
[ ] (UMLS (ICD9CM) C0270025) =Pathologic Function
965. FGFR3
[This gene plays a role in bone development and maintenance and mutations in the gene are associated with craniosynostosis and several types of skeletal dysplasia. ( NCI )] (UMLS (NCI) C1333543) FGFR3 Gene;
Fibroblast Growth Factor Receptor 3 (Achondroplasia, Thanatophoric Dwarfism) Gene =Gene or Genome ;
916. Fetus or newborn affected by maternal complications of pregnancy
[ ] (UMLS (ICD9CM) C0158816) =Disease or Syndrome
966. FGFR4
[Encoded by human FGFR4 Gene (FGFR Family), 802-amino acid 87.9 kD (precursor) type I membrane protein Fibroblast Growth Factor Receptor 4 is a receptor tyrosine kinase with three extracellular Ig-like C2-type domains, a cytoplasmic tyrosine kinase domain, and 55% amino acid identity with FLG (FGFR1) and BEK. FGFR family amino acid sequence is highly conserved; the extracellular domain interacts with FGFs, signaling downstream cascades that influence mitogenesis and differentiation. FGFRs differ in ligand affinities and tissue distribution. Predominantly expressed in lung, FGFR4 expression is distinct from FLG, BEK, and FGFR3. Unlike FGFR1-3, FGFR4 IgIII domain C-terminal half does not vary. Although function is unknown, FGFR4 preferentially binds acidic FGF and FGF19; it does not bind to basic FGF. (from Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0117719) =Amino Acid, Peptide, or Protein; Receptor ;
917. Fetus or newborn affected by maternal conditions which may be unrelated to present pregnancy
[ ] (UMLS (ICD9CM) C0158799) =Disease or Syndrome
967. FGFR4
[This gene plays a role in mitogenesis and differentiation. ( NCI )] (UMLS (NCI) C1333544) FGFR4 Gene;
Fibroblast Growth Factor Receptor 4 Gene =Gene or Genome ;
918. Fetus or newborn affected by other complications of labor and delivery
[ ] (UMLS (ICD9CM) C0473833) =Disease or Syndrome ;
968. FGFRL1
[Encoded by human FGFRL1 Gene (FGFR Family), at 504-aa 54.6-kDa conserved Fibroblast Growth Factor Receptor-Like 1 consists of an extracellular region (containing 3 Ig-like domains), a hydrophobic transmembrane segment, and a cytoplasmic tail lacking a tyrosine kinase domain. This protein may interact with other family members and inhibit growth factor signaling. (NCI) ( NCI )] (UMLS (NCI) C0962882) Fibroblast Growth Factor Receptor-Like 1;
=Amino Acid, Peptide, or Protein; Receptor ;
919. fetus pharmacology
[ ] (UMLS (CSP) C0920520) =Biomedical Occupation or Discipline
969. FGFRL1
[This gene plays a role in the regulation of receptor cellular signal transduction. ( NCI )] (UMLS (NCI) C1364012) FGFRL1 Gene;
Fibroblast Growth Factor Receptor-Like 1 wt Gene =Gene or Genome
920. fetus pharmacotherapy
[ ] (UMLS (CSP) C1328879) =Therapeutic or Preventive Procedure ;
970. FGR
[This gene plays a role in the regulation of cell migration and adhesion. ( NCI )] (UMLS (NCI) C0919478) FGR Gene;
Gardner-Rasheed Feline Sarcoma Viral (V-FGR) Oncogene Homolog Gene;
Oncogene FGR =Gene or Genome ;
921. fetus preservation
[ ] (UMLS (CSP) C0920521) =Laboratory Procedure
971. FGS (focal glomerular sclerosis)
[A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE. ( MSH )] (UMLS (CSP) C0017668) =Disease or Syndrome ;
=glomerulonephritis;
922. fetus therapy
[Prenatal interventions to correct fetal anomalies or treat FETAL DISEASES in utero. Fetal therapies include several major areas, such as open surgery; FETOSCOPY; pharmacological therapy; INTRAUTERINE TRANSFUSION; STEM CELL TRANSPLANTATION; and GENE THERAPY. ( MSH )] (UMLS (CSP) C0015952) =Therapeutic or Preventive Procedure
972. FHA (functional hypothalamic amenorrhea)
[ ] (UMLS (CSP) C0597821) =Pathologic Function
923. fetus toxicology
[ ] (UMLS (CSP) C0920522) =Biologic Function
973. FHIT
[This gene is involved in nucleotide metabolism and cell cycle control. ( NCI )] (UMLS (NCI) C0919457) FHIT Gene;
Fragile Histidine Triad Gene;
=Gene or Genome ;
924. fetus transplantation
[ ] (UMLS (CSP) C0920523) =Therapeutic or Preventive Procedure
974. FHL2
[This gene is involved in cellular signaling and the mediation of protein-protein interactions. ( NCI )] (UMLS (NCI) C1333547) FHL2 Gene;
Four and a Half LIM Domains 2 Gene =Gene or Genome ;
925. FEV increased
[An increase in the fraction of the forced vital capacity that is exhaled in a specific number of seconds. ( NCI )] (UMLS (NCI) C0520836) =Finding
975. FI
[A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. (NCI) ( NCI )] (UMLS (NCI) C0016132) =Geographic Area
926. FEV1
[A test of lung function, the FEV1 is the volume exhaled during the first second of a forced expiratory maneuver started from the level of total lung capacity. It is the most frequently used index for assessing bronchoconstriction or bronchodilatation. ( NCI )] (UMLS (NCI) C0849974) FEV1%VC;
Forced Expiratory Volume 1 Test;
Forced Expiratory Volume in 1 Second;
PFT/FEV1;
Pulmonary Function Test/Forced Expiratory Volume 1;
=Diagnostic Procedure
976. Fiber
[Animals raised for their fur, hair or skins ( HL7V3.0 )] (UMLS (HL7) C1556142) =Intellectual Product =LivingSubjectProductionClass;
927. Fever
[abnormal elevation of body temperature, usually as a result of a pathologic process.(CSP)] (UMLS (ICPC) C0015967) (Fever; SUKARRA; Feber; Koorts; KUUME; Fievre; Fieber; xom; laz; Febbre; FEBER; Febre; Fiebre; FEBER) =Finding =body temperature; Body Temperature Changes; Clinical Finding; GENERAL AND UNSPECIFIED; Symptoms and Complaints Component; =Febrile convulsions (simple), unspecified; anesthesia related hyperthermia; Fever of Unknown Origin; Sweating Sickness;
977. fiber
[The parts of fruits and vegetables that cannot be digested. Also called bulk or roughage. Fiber may be effective in preventing cancer. ( NCI )] (UMLS (NCI) C0225326) =Pharmacologic Substance =[TN200] ENTERAL NUTRITION;
Unclassified Ingredients =FIBERMED HIGH-FIBER SUPPLEMENT;
FIBERMED HIGH-FIBER MINIATURE FRUIT;
FIBERMED HIGH-FIBER SUPPLEMENT FRUIT;
FIBER 14.4 GM/L;
FIBER 3.4 GM/240ML;
FIBER 8.9 GM/L
928. Fever Chills
(UMLS (NCI) C0085594) =Sign or Symptom
978. fiber cell
[an elongated cell or aggregation of cells forming a strand, e.g. muscle, nerve, or connective tissue. ( CSP )] (UMLS (CSP) C0596568) =Cell = ;
929. Fever of Unknown Origin
[Fever in which the etiology cannot be ascertained. ( MSH )] (UMLS (NCI) C0015970) =Sign or Symptom =Febbre;
979. fiber optic microscopy
[ ] (UMLS (CSP) C0596569) =Laboratory Procedure =microscopy;
930. Few
(UMLS (NCI) C0205388) =Quantitative Concept
980. Fiber Optic Transilluminator
[A light, with glass or plastic fibers which have special optical properties usually attached to a dental handpiece that is intended to illuminate oral structures. ( NCI )] (UMLS (NCI) C0493998) =Medical Device
931. Fexinidazole
(UMLS (NCI) C0060304) =Organic Chemical; Pharmacologic Substance ;
981. fiber optics
[branch of science concerned with optic fibers, which are transparent thin fibers, as small as a human hair, used for the transmission of light; optic fibers can be used as a medium for telecommunication and computer networking; may be made of plastic or glass. ( CSP )] (UMLS (CSP) C0015979) =Occupation or Discipline =Optical;
932. FEXOFENADINE
[A second generation, long-lasting selective histamine H1 receptor antagonist with antiinflammatory property. Fexofenadine is a highly selective and reversible competitor at peripheral H1 histamine receptors in the gastrointestinal (GI) tract, blood vessels, and bronchial smooth muscle. This agent interferes with mediators release from mast cells either by inhibiting calcium ion influx across mast cell/basophil plasma membrane or by inhibiting intracellular calcium ion release within the cells. In addition fexofenadine may also inhibit the late-phase allergic reaction by acting on leukotrienes or prostaglandins, or by producing an anti-platelet activating factor effect. Overall, this agent blocks the actions of endogenous histamine, thereby leads to temporary relief of the negative symptoms associated with histamine and achieve effects such as decreased vascular permeability, reduction of pruritus and localized smooth muscle relaxation. ( NCI )] (UMLS (NCI) C0296800) =Organic Chemical; Pharmacologic Substance ;
=Terfenadine;
[AH600] ANTIHISTAMINES, BUTYROPHENONE =Fexofenadine HCl
982. FIBER-OPTIC BRONCHOSCOPY
[ ] (UMLS (ICD9CM) C0189391) =Diagnostic Procedure ;
933. Fexofenadine HCl
[The hydrochloride salt form of fexofenadine, a carboxylated metabolic derivative of terfenadine and third generation selective histamine H1-receptor antagonist with antihistaminic and non-sedative effects. Fexofenadine competitively binds peripheral H1-receptors, thereby stabilizing an inactive conformation of the receptor. Consequently histamine binding and activity as a result of mast-cell degranulation followed by the release of multiple inflammatory mediators, such as interleukins, prostaglandin and leukotriene precursors, is blocked, thereby preventing the triggering of pro-inflammatory pathways. ( NCI )] (UMLS (NCI) C0771752) Fexofenadine Hydrochloride;
FEXOFENADINE HYDROCHLORIDE PREPARATION;
=Organic Chemical; Pharmacologic Substance =FEXOFENADINE;
=FEXOFENADINE HYDROCHLORIDE 60 MG;
FEXOFENADINE HYDROCHLORIDE 180 MG;
FEXOFENADINE HYDROCHLORIDE 30 MG
983. Fibercon
(UMLS (NCI) C0720432) =Organic Chemical; Pharmacologic Substance
934. FFA
[fatty acids found in the plasma that are complexed with serum albumin for transport; these fatty acids are not in glycerol ester form. ( CSP )] (UMLS (CSP) C0015688) =Lipid =Fatty Acid;
blood lipid
984. Fiberglass
[A manufactured fiber in which the fiber-forming substance is glass. Silicon dioxide is the primary chemical component in all glass types; however, many other metal oxides are present. Respirable glass wool has a mass median aerodynamic diameter of approximately 3.5 um or less. Fibers less than 1 um in diameter have the highest probability for deposition in the alveolar regions of the lung, where gas exchange occurs. The major uses of glass wool are in thermal, electrical, and acoustical insulation, weatherproofing and filtration media. The highest levels of occupational exposure to this fiber occur when it is used in confined spaces. The primary routes of potential human exposure to glass wool are inhalation and dermal and/or eye contact. It is reasonably anticipated to be a human carcinogen. ( NCI )] (UMLS (NCI) C0060317) =Biomedical or Dental Material; Hazardous or Poisonous Substance ;
935. FG
[A country in Northern South America, bordering the North Atlantic Ocean, between Brazil and Suriname. (NCI) ( NCI )] (UMLS (NCI) C0016703) =Geographic Area ;
985. FIBP
[This gene plays a role in transcription and is involved in mitogenesis. ( NCI )] (UMLS (NCI) C1333548) FIBP Gene;
Fibroblast Growth Factor (Acidic) Intracellular Binding Protein Gene =Gene or Genome ;
936. FGF Receptor
[Family of receptor tyrosine kinases for fibroblast growth factor. Amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. ( NCI )] (UMLS (NCI) C0060369) =Amino Acid, Peptide, or Protein; Receptor ;
986. Fibrillary Astrocytoma
[The most frequent histological variant of diffuse astrocytoma. It is predominantly composed of fibrillary neoplastic astrocytes. Nuclear atypia is a diagnostic criterion but mitotic activity, necrosis and microvascular proliferation are absent. The occasional or regional occurrence of gemistocytic neoplastic cells is compatible with the diagnosis of fibrillary astrocytoma. (WHO) ( NCI )] (UMLS (NCI) C0334582) =Neoplastic Process
937. FGF Receptor Activating Protein 1
[Encoded by human FRAG1 Gene, FGF Receptor Activating Protein 1 appears to be a 315-aa 36-kDa membrane-spanning protein whose function is not currently known. FRAG1 resides in a chromosome region implicated in Beckwith-Wiedemann syndrome and frequent loss of heterozygosity in multiple tumor types. (from Proc Natl Acad Sci 1996;93:8956-61 and Genomics 1999;62:59-66) ( NCI )] (UMLS (NCI) C1313485) FRAG1;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
987. Fibrillation, ventricular
[arrhythmia characterized by fibrillary contractions of the ventricular muscle due to rapid repetitive excitation of myocardial fibers without coordinated contraction of the ventricle. ( CSP )] (UMLS (NCI) C0042510) =Disease or Syndrome =arrhythmia;
938. FGF1
[This gene plays a role in angiogenesis and organogenesis. It is also involved in the regulation of endothelial cell migration and proliferation. ( NCI )] (UMLS (NCI) C1333536) FGF1 Gene;
Fibroblast Growth Factor 1 (Acidic) Gene =Gene or Genome ;
988. Fibrillin
[350 kD glycoprotein; major component of the extracellular microfibril. ( CSP )] (UMLS (NCI) C0060321) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=glycoprotein;
939. FGF10
[This gene is involved in development and wound healing. It also plays a role in cellular biogenesis, organization and proliferation. ( NCI )] (UMLS (NCI) C1333535) FGF10 Gene;
Fibroblast Growth Factor 10 Gene =Gene or Genome ;
989. fibrin
[insoluble protein that forms a network of fibers during blood clotting; derived from fibrinogen in the presence of thrombin. ( CSP )] (UMLS (CSP) C0015982) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance =antithrombin;
Blood Coagulation Factor
940. FGF2
[This gene is involved in angiogenesis, development and cell cycle control. ( NCI )] (UMLS (NCI) C0919506) FGF2 Gene;
Fibroblast Growth Factor 2 (Basic) Gene;
=Gene or Genome ;
990. Fibrin
[The Fibrin Index of the specimen. In the case of only differentiating between Absent and Present, recommend using 0 and 1 ( HL7V3.0 )] (UMLS (HL7) C1553191) =Intellectual Product =ActSpecObsInterferenceCode;
941. FGF20
[Expressed in brain by human FGF20 Gene (FGF Family), 211-aa 23.5-kDa Fibroblast Growth Factor 20 contains a strong hydrophobic region in its FGF core domain and a weak hydrophobic N terminal region. FGF20 may enhance the survival of midbrain dopaminergic neurons. (NCI) ( NCI )] (UMLS (NCI) C0962069) Fibroblast Growth Factor 20;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
991. fibrin sealant
[A type of surgical glue that is made from human blood-clotting proteins, and that is used during surgery to control bleeding. ( NCI )] (UMLS (NCI) C0016004) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biomedical or Dental Material
942. FGF20
[This gene plays a role in development, cell growth, morphogenesis and tissue repair. ( NCI )] (UMLS (NCI) C1333537) FGF20 Gene;
Fibroblast Growth Factor 20 Gene =Gene or Genome ;
992. FIBRINO
[A quantitative measurement of the amount of fibrinogen present in a sample. ( NCI )] (UMLS (NCI) C0337428) =Laboratory Procedure
943. FGF21
[Fibroblast Growth Factor 21 (209-aa 22-kDa precursor) is encoded by human FGF21 Gene (FGF Family). FGF family members possess broad mitogenic and cell survival activities and are involved in a variety of biological processes including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. The function of this growth factor has not yet been determined. (NCI) ( NCI )] (UMLS (NCI) C0972232) Fibroblast Growth Factor 21 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
993. fibrinogen receptor
[receptors that bind fibrinogen through distinct adhesive sequences on the fibrinogen molecule. ( CSP )] (UMLS (CSP) C1136300) =Amino Acid, Peptide, or Protein; Receptor ;
=Extracellular Matrix, Integrins;
944. FGF21
[This gene plays a role in signal transduction. ( NCI )] (UMLS (NCI) C1333538) FGF21 Gene;
Fibroblast Growth Factor 21 Gene =Gene or Genome ;
994. fibrinogenase
[A formulated therapeutic agent that contains endogenously produced thrombin isolated from human or animal plasma. (NCI04) ( NCI )] (UMLS (CSP) C0040018) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Enzyme =Blood Coagulation Factor;
Serine Endopeptidases;
[BL300] ANTIHEMORRHAGICS;
[PH000] PHARMACEUTICAL AIDS / REAGENTS;
Additive/Preservative;
=THROMBIN 10000 UNT;
THROMBIN 20000 UNT;
THROMBIN 50000 UNT;
THROMBIN 1000 UNT;
THROMBIN 5000 UNT;
945. FGF3
[Fibroblast Growth Factor 3 is a member of the FGF family. Fibroblast growth factors have been associated with mesoderm induction and FGF3 has a distinct pattern of expression throughout development in vertebrates. FGF3 constitutes a signal for induction of the otic vesicle, the primordium of the inner ear. (from OMIM 164950 and NCI) ( NCI )] (UMLS (NCI) C0208989) =Amino Acid, Peptide, or Protein; Biologically Active Substance
995. Fibrinoid Necrosis
(UMLS (NCI) C0333513) =Pathologic Function
946. FGF3
[This gene plays a role in the regulation of cell growth. ( NCI )] (UMLS (NCI) C0812290) FGF3 Gene;
Fibroblast Growth Factor 3 (Murine Mammary Tumor Virus Integration Site (v-int-2) Oncogene Homolog) Gene;
=Gene or Genome
996. fibrinolysis
[natural enzymatic dissolution of fibrin. ( CSP )] (UMLS (CSP) C0016017) =Physiologic Function =blood coagulation;
947. FGF4
[Fibroblast Growth Factor 4 is a heparin-binding growth factor with significant homology to human fibroblast growth factors that appears to function in limb development in conjunction with the SHH pathway. (from OMIM 164980 and NCI) ( NCI )] (UMLS (NCI) C0084220) =Amino Acid, Peptide, or Protein; Biologically Active Substance
997. fibrinolytic therapy
[use of infusions of fibrinolytic agents to destroy or dissolve thrombi in blood vessels or in bypass grafts. ( CSP )] (UMLS (NCI) C0040044) =Therapeutic or Preventive Procedure =cardiovascular disorder chemotherapy;
948. FGF4
[This gene is involved in development and spermatogenesis. ( NCI )] (UMLS (NCI) C0919466) FGF4 Gene;
FGF4 Oncogene;
Fibroblast Growth Factor 4 (Heparin Secretory Transforming Protein 1, Kaposi Sarcoma Oncogene) Gene;
Fibroblast Growth Factor 4 Oncogene;
HSTF1;
Human Stomach Cancer Derived Oncogene;
Kaposi Sarcoma Oncogene;
K-FGF;
Oncogene HST =Gene or Genome ;
998. fibrinopeptide
[proteolytic fragments cleaved from fibrinogen by thrombin to form fibrin; measured as an indicator of thrombogenesis, and may be functionally important in blood coagulation. ( CSP )] (UMLS (CSP) C0178635) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Blood Coagulation Factor;
949. FGF5
[A member of the heparin-binding growth factor family, FGF5 is expressed in neonatal brain. Two isoforms (long and short) are produced by alternative splicing. (from OMIM 165190 and NCI) ( NCI )] (UMLS (NCI) C0117720) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
999. FIBROADENOSIS OF BREAST
[ ] (UMLS (ICD9CM) C1305875) =Disease or Syndrome ;
950. FGF5
[This gene plays a role in the stimulation of cell proliferation. ( NCI )] (UMLS (NCI) C0919508) FGF5 Gene;
Fibroblast Growth Factor 5 Gene;
=Gene or Genome ;
1000. fibroblast
[connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. ( CSP )] (UMLS (NCI) C0016030) =Cell =Connective and Soft Tissue Cell;
Pluripotent Stem Cell

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.

 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM